This story has been updated from a previous version.

NEW YORK, April 11 - MediChem Life Sciences of Chicago said Wednesday it had signed its first protein structure deal with Celgene’s Signal Research Division, reflecting outside interest in MediChem’s drug discovery strategy, which combines its recently acquired X-ray crystallography and informatics capabilities along with its traditional medicinal chemistry approach.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.